1518
H. Werner et al. / Inorganica Chimica Acta 358 (2005) 1510–1520
C, 74.22; H, 5.07%. MS (FAB, 2-nitrophenyloctylether):
m/z 660 (M+), 544 (M+ ꢀ C9H8), 479 (M+ ꢀ H–
3.15. Preparation of exo/endo- [(g5-C9H7)RuH(CH2@
CHPh)(PPh3)] (18a,18b)
1
CH2@CPh2). H NMR (C6D6, 400 MHz): d 7.64–6.72
(br m, 29H, C6H5 and C6H4 part of C9H7), 5.83 [t, 1H,
3J(HH) = 2.6 Hz, H2 of C3H3 part of C9H7], 4.41, 3.55
(both br s, 1H each, H1 and H3 of C3H3 part of C9H7),
3.18 (br s, 1H, one H of @CH2), 1.75 [dd, 1H,
This compound was prepared analogously as de-
scribed for 15, with 104 mg (0.17 mmol) of 10 and
0.22 ml of a 1.60 M solution of methyllithium (0.34
mmol) in diethyl ether. Yellow microcrystalline solid;
yield 64 mg (64%); m.p. (decomposition) 79 ꢁC. Anal.
Calc. for C35H31PRu: C, 72.01; H, 5.36. Found: C,
71.50; H, 5.81%. Owing to the NMR spectroscopic data
a mixture of exo/endo isomers 18a,18b in the ratio of 4:3
was obtained. Data for 18a: 1H NMR (C6D6, 400
MHz): d 7.48–6.55 (br m, C6H5 and C6H4 part of
C9H7), 5.29 [dt, 1H, 2J(PH) = 1.6, 3J(HH) = 2.6 Hz,
H2 of C3H3 part of C9H7], 4.75, 4.56 (both br s, 1H
each, H1 and H3of C3H3 part of C9H7), 3.53 (m, 1H,
@CHPh), 3.05 [d, 1H, 3J(HH) = 10.1 Hz, one H of
@CH2], 1.10 [dd, 1H, 3J(PH) = 10.7, 3J(HH) = 10.1
3
3J(PH) = 13.2, J(HH) = 1.6 Hz, one H of @CH2], ꢀ
12.56 [d, 1H, 2J(PH) = 36.0 Hz, RuH]. C13 NMR
(C6D6, 100.6 MHz): d 153.5, 149.8 (both s, ipso-C of
CC6H5), 137.6 [d, J(PC) = 43.0 Hz, ipso-C of PC6H5],
1
2
133.8 [d, J(PC) = 10.6 Hz, ortho-C of PC6H5], 132.8,
128.8, 127.8, 127.2 (all s, ortho- and meta-C of CC6H5),
3
128.7 [d, J(PC) = 2.9 Hz, para-C of PC6H5], 127.5 [d,
3J(PC) = 9.6 Hz, meta-C of PC6H5], 125.1, 125.0 (both
s, para-C of CC6H5), 124.4, 123.9, 123.0, 122.4 (all s,
C6–9 of C9H7), 110.6, 107.5 (both s, C1 and C5 of C9H7),
88.5 [d, 2J(PC) = 2.9 Hz, C3 of C9H7], 88.3 [d,
2J(PC) = 9.6 Hz, C2 or C4 of C9H7], 74.0 (s, C2 or C4 of
C9H7), 34.4 (s, @CH2); for assignment of indenyl carbon
atoms, see Fig. 1. 31P NMR (C6D6, 162.0 MHz): d 67.7 (s).
2
Hz, one H of @CH2], ꢀ 12.21 [d, 1H, J(PH) = 39.1
Hz, RuH]. C13 NMR (C6D6, 100.6 MHz): d 150.0 (s,
ipso-C of CC6H5), 136.6 [d, J(PC) = 42.9 Hz, ipso-C
1
of PC6H5], 133.6 [d, 2J(PC) = 10.5 Hz, ortho-C of
3.14. Preparation of [(g5-C9H7)Ru(g3-1-PhC3H4)-
(PPh3)] (17)
PC6H5], 129.2 [d, J(PC) = 1.9 Hz, para-C of PC6H5],
128.1, 124.3 (both s, ortho- and meta-C of CC6H5),
3
3
127.9 [d, J(PC) = 9.5 Hz, meta-C of PC6H5], 126.2 (s,
A solution of 107 mg (0.18 mmol) of 10 in 5 ml of tol-
uene was treated with 0.55 ml of a 0.65 M solution of
CH2@CHMgBr (0.36 mmol) in THF and stirred for
45 min at r.t. The reaction mixture was worked up as de-
scribed for 3. Yellow microcrystalline solid; yield 81 mg
(76%); m.p. (decomposition) 172 ꢁC. Anal. Calc. for
C36H31PRu: C, 72.58; H, 5.26. Found: C, 72.28; H,
5.29%. MS (FAB, 2-nitrophenyloctylether): m/z 596
(M+), 479 (M+ ꢀ PhC3H4), 334 (M+ ꢀ PPh3). 1H
NMR (C6D6, 400 MHz): d 7.74–6.62 (br m, 24H,
C6H5 and C6H4 part of C9H7), 4.80 [dddd, 1H,
3J(PH) = 1.5, 3J(HH) = 9.4, 9.2 and 6.9 Hz, CHCH
CH2], 4.45, 4.40 (both br s, 1H each, H1 and H3of
para-C of CC6H5), 125.2, 124.3, 123.6, 123.2 (all s,
C6–9 of C9H7), 110.0 (s, C1 or C5 of C9H7), 109.5 [d,
2J(PC) = 1.9 Hz, C1 or C5 of C9H7], 87.0 [d,
2J(PC) = 2.9 Hz, C3 of C9H7], 86.0 [d, 2J(PC) = 10.5
Hz, C2 or C4 of C9H7], 71.8 (s, C2 or C4 of C9H7),
2
48.9 (s, @CHPh), 26.9 [d, J(PC) = 4.8 Hz, @CH2]; for
assignment of indenyl carbon atoms, see Fig. 1. 31P
NMR (C6D6, 162.0 MHz): d 71.3 (s). ꢀ Data for 18b:
1H NMR (C6D6, 400 MHz): d 7.48–6.55 (br m, C6H5
and C6H4 part of C9H7), 5.77 [d, 1H, 3J (HH) = 2.6
2
Hz, H1 or H3 of C3H3 part of C9H7], 5.74 [dt, 1H, J
(PH) = 1.6, 3J(HH) = 2.6 Hz, H2 of C3H3 part of
C9H7], 4.34 (br s, 1H, H1 or H3of C3H3 part of
C9H7), 2.81 [t, 1H, 3J(HH) = 8.1 Hz, = CHPh], 1.81
[dd, 1H, 2J(PH) = 2.4, 3J(HH) = 8.1 Hz, one H of
@CH2], 0.86 [t, 1H, 3J(HH) = 8.1 Hz, one H of
3
C3H3 part of C9H7), 4.32 [t, 1H, J(HH) = 2.9 Hz, H2
of C3H3 part of C9H7], 2.55 [dd, 1H, 3J(PH) = 1.2,
3J(HH) = 6.9 Hz, CH CHCH2], 1.98 [dd, 1H,
3J(PH) = 12.6, 3J(HH) = 9.4 Hz, Hsyn of allyl-CH2],
2
@CH2], ꢀ 13.06 [d, 1H, J(PH) = 39.9 Hz, RuH]. C13
3
3
0.52 [dd, 1H, J(PH) = 15.1, J(HH) = 9.2 Hz, Hanti of
allyl-CH2]. C13 NMR (C6D6, 100.6 MHz): d 148.3 (s,
ipso-C of CC6H5), 136.8 [d, J(PC) = 38.2 Hz, ipso-C
NMR (C6D6, 100.6 MHz): d 148.9 (s, ipso-C of
CC6H5), 136.9 [d, J(PC) = 42.9 Hz, ipso-C of PC6H5],
1
1
2
133.7 [d, J(PC) = 10.5 Hz, ortho-C of PC6H5], 129.3
of PC6H5], 134.9 [d, 2J(PC) = 10.2 Hz, ortho-C of
PC6H5], 129.1 (s, para-C of PC6H5), 128.4, 125.4 (both
[d, 3J(PC) = 2.9 Hz, para-C of PC6H5], 128.2, 126.2
(both s, ortho- and meta-C of CC6H5), 127.8 [d,
3J(PC) = 9.5 Hz, meta-C of PC6H5], 126.9 (s, para-C
of CC6H5), 124.1, 123.8, 123.7, 121.8 (all s, C6–9 of
3
s, ortho- and meta-C of CC6H5), 127.7 [d, J(PC) = 8.9
Hz, meta-C of PC6H5], 124.5, 124.4, 123.8, 123.7 (all s,
C6–9 of C9H7), 122.9 (s, para-C of CC6H5), 101.4,
100.2 (both s, C1 and C5 of C9H7), 89.2 (s, C3 of
2
C9H7), 110.5 [d, J(PC) = 2.9 Hz, C1 or C5 of C9H7],
2
109.6 [s, C1 or C5 of C9H7], 87.1 [d, J(PC) = 1.9 Hz,
2
C9H7), 73.6, 72.8 [both d, J(PC) = 3.8 Hz, C2 and C4
C3 of C9H7], 79.3 [d, 2J(PC) = 10.5 Hz, C2 or C4 of
C9H7], 69.3 [d, 2J(PC) = 1.9 Hz, C2 or C4 of C9H7],
of C9H7], 65.9 (s, CHCHCH2), 54.0 [d, 2J(PC) = 2.5
Hz, CHCHCH2], 36.0 [d, 2J(PC) = 6.4 Hz, CH2]; for
assignment of indenyl carbon atoms, see Fig. 1. 31P
NMR (C6D6, 162.0 MHz): d 64.8 (s).
2
47.2 [d, J(PC) = 1.9 Hz, = CHPh], 27.0 [s, @CH2]; for
assignment of indenyl carbon atoms, see Fig. 1. 31P
NMR (C6D6, 162.0 MHz): d 67.9 (s).